BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)
Identifiers
Identifiers
Services
Services
Date issued
2013Journal title
HEMATOLOGICAL ONCOLOGY
Type of content
Publicación de congreso
